Anemia and clinical outcomes in hepatitis C.
Benhamou
Yves
Y
D000740:Anemia / Q000139:chemically induced / Q000517:prevention & control*; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D012254:Ribavirin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
D000998:Antiviral Agents; D012254:Ribavirin; C026956:taribavirin